In this edition of The Motley Fool's Market Checkup, health-care analysts David Williamson and Max Macaluso discuss emerging treatments for obesity. From Mayor Bloomberg's controversial soda ban in New York to new medications just hitting the market, this continues to be a hotly debated disease.
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Market Checkup: Obesity
In this edition of "Market Checkup," our health-care analysts discuss emerging treatments for obesity.
David Williamson owns shares of Coca-Cola. Max Macaluso, Ph.D. owns shares of Starbucks. The Motley Fool recommends Coca-Cola, Johnson & Johnson, McDonald's, PepsiCo, and Starbucks and owns shares of Johnson & Johnson, McDonald's, PepsiCo, and Starbucks. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Related Articles





Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.